HCV Disease Progression
Cured Hepatitis C Patients May Have Same Life Expectancy as General Population
- Details
- Category: HCV Disease Progression
- Published on Friday, 19 December 2014 00:00
- Written by Liz Highleyman
Chronic hepatitis C patients with advanced liver fibrosis or cirrhosis who achieve sustained virological response to treatment have a life expectancy matching that of the general population, according to findings from a retrospective study published in the November 12 Journal of the American Medical Association. Those who were not cured, however, had significantly reduced survival.
AASLD 2014: Many Hepatitis C Patients with Cirrhosis or Advanced Fibrosis Face Liver Failure
- Details
- Category: HCV Disease Progression
- Published on Friday, 12 December 2014 00:00
- Written by Liz Highleyman
Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within 5 years, and 23% and 11%, respectively, died, according to a study presented at the American Association for the Study of Liver Diseases (AASLD) Liver Meetinglast month in Boston. These findings underscore the urgent need for treatment for such individuals.
Coverage of the 2014 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 02 December 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014) in Boston, November 7-11, 2014.
Conference highlights include new interferon-free therapy for hepatitis C -- including options for people with cirrhosis, and liver transplant recipients -- treatment for hepatitis B, and prevention and management of advanced liver disease.
12/2/14
Coverage of the 2014 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 02 December 2014 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 65th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2014) in Boston, November 7-11, 2014.
Conference highlights include new interferon-free therapy for hepatitis C -- including options for people with cirrhosis, and liver transplant recipients -- treatment for hepatitis B, and prevention and management of advanced liver disease.
12/2/14
AASLD 2014: HIV Positive People Have High Survival Rates After Liver Transplants Due to HCC
- Details
- Category: Liver Transplant - HCV
- Published on Monday, 10 November 2014 00:00
- Written by Liz Highleyman
People with HIV -- most of whom were coinfected with hepatitis B or C -- generally had good outcomes after liver transplantation due to hepatocellular carcinoma (HCC), with 5-year survival rates similar to those of HIV negative transplant recipients and better than those of people who underwent other types of liver cancer treatment, researchers reported at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting this week in Boston.
More Articles...
- IDWeek 2014: Age, Sex, and Race Predict Spontaneous Hepatitis C Virus Clearance
- HCV Genotype 3, Hispanic Ethnicity Linked to Higher Risk of Cirrhosis, Liver Cancer
- CROI 2014: How Fast Does Fibrosis Progress in Acute Hepatitis C Patients with and without HIV?
- DDW 2014: Drinking More Coffee Is Associated with Less Liver Fibrosis
Web Design and Development by